These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3068631)
1. [Massive therapy and transplant of autologous bone marrow in childhood lymphomas and solid tumors. State of the art and perspectives]. de Terlizzi M; Philip T; Toma MG; Colella R; Ceci A Pediatr Med Chir; 1988; 10(4):359-64. PubMed ID: 3068631 [TBL] [Abstract][Full Text] [Related]
2. [Massive chemotherapy and bone marrow autografts in solid tumors and non-leukemic lymphomas in pediatrics]. Philip T; Bouffet E; Biron P; Philip I; Brunat-Mentigny M Ann Pediatr (Paris); 1984 Oct; 31(9):745-52. PubMed ID: 6395777 [No Abstract] [Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
4. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163 [TBL] [Abstract][Full Text] [Related]
5. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Schmid H; Henze G; Schwerdtfeger R; Baumgarten E; Besserer A; Scheffler A; Serke S; Zingsem J; Siegert W Bone Marrow Transplant; 1993 Dec; 12(6):597-602. PubMed ID: 8136744 [TBL] [Abstract][Full Text] [Related]
6. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Stein RS; Greer JP; Goodman S; Kallianpur A; Ahmed MS; Wolff SN Bone Marrow Transplant; 1999 Feb; 23(3):227-33. PubMed ID: 10084253 [TBL] [Abstract][Full Text] [Related]
7. Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma. Vose JM; Armitage JO Hematol Oncol Clin North Am; 1993 Jun; 7(3):577-90. PubMed ID: 8102135 [TBL] [Abstract][Full Text] [Related]
8. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation. Deeg HJ; Appelbaum FR; Weiden PL; Hackman RC; Graham TC; Storb RC Am J Vet Res; 1985 Sep; 46(9):2016-8. PubMed ID: 3901841 [TBL] [Abstract][Full Text] [Related]
9. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients]. Wang H; Cui X; Shao Y Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783 [TBL] [Abstract][Full Text] [Related]
11. [High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study]. Wu GQ Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):47-51. PubMed ID: 7687533 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624 [TBL] [Abstract][Full Text] [Related]
14. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460 [TBL] [Abstract][Full Text] [Related]
15. [Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor]. Endo M; Tanosaki R Gan To Kagaku Ryoho; 1995 Oct; 22(12):1762-70. PubMed ID: 7574807 [TBL] [Abstract][Full Text] [Related]
16. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)]. Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255 [TBL] [Abstract][Full Text] [Related]
17. [High dose therapy with transplantation of autologous peripheral hematopoietic stem cells. II. Indications and clinical results]. Gunsilius E; Petzer A; Gastl G Acta Med Austriaca; 1997; 24(3):102-7. PubMed ID: 9312972 [TBL] [Abstract][Full Text] [Related]
18. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma. Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593 [TBL] [Abstract][Full Text] [Related]
19. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. Blume KG; Long GD; Negrin RS; Chao NJ; Kusnierz-Glaz C; Amylon MD Bone Marrow Transplant; 1994; 14 Suppl 4():S9-10. PubMed ID: 7728133 [TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation using TBI and CBV for disseminated high/intermediate grade cutaneous non-epidermotropic non-Hodgkin's lymphoma. Moreau P; LeTortorec S; Mahé MA; Mahé B; Moreau A; Bourdin S; Bulabois CE; Bureau B; Harousseau JL; Milpied N Bone Marrow Transplant; 1994 Nov; 14(5):775-8. PubMed ID: 7889011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]